Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease

J Nutr Biochem. 2014 Jul;25(7):801-6. doi: 10.1016/j.jnutbio.2014.03.006. Epub 2014 Apr 1.

Abstract

This study investigated the effect of naringin, a major flavonoid in grapefruit and citrus fruits, on the degeneration of the nigrostriatal dopaminergic (DA) projection in a neurotoxin model of Parkinson's disease (PD) in vivo and the potential underlying mechanisms focusing on the induction of glia-derived neurotrophic factor (GDNF), well known as an important neurotrophic factor involved in the survival of adult DA neurons. 1-Methyl-4-phenylpyridinium (MPP(+)) was unilaterally injected into the medial forebrain bundle of rat brains for a neurotoxin model of PD in the presence or absence of naringin by daily intraperitoneal injection. To ascertain whether naringin-induced GDNF contributes to neuroprotection, we further investigated the effects of intranigral injection of neutralizing antibodies against GDNF in the MPP(+) rat model of PD. Our observations demonstrate that naringin could increase the level of GDNF in DA neurons, contributing to neuroprotection in the MPP(+) rat model of PD, with activation of mammalian target of rapamycin complex 1. Moreover, naringin could attenuate the level of tumor necrosis factor-α in microglia increased by MPP(+)-induced neurotoxicity in the substantia nigra. These results indicate that naringin could impart to DA neurons the important ability to produce GDNF as a therapeutic agent against PD with anti-inflammatory effects, suggesting that naringin is a beneficial natural product for the prevention of DA degeneration in the adult brain.

Keywords: 1-Methyl-4-phenylpyridinium; GDNF; Naringin; Neuroprotection; Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity
  • Animals
  • Disease Models, Animal
  • Dopamine / physiology*
  • Female
  • Flavanones / pharmacology*
  • Glial Cell Line-Derived Neurotrophic Factor / biosynthesis*
  • Glial Cell Line-Derived Neurotrophic Factor / immunology
  • Neuroprotective Agents / pharmacology*
  • Parkinson Disease / physiopathology*
  • Rats, Sprague-Dawley
  • Substantia Nigra / drug effects*

Substances

  • Flavanones
  • Glial Cell Line-Derived Neurotrophic Factor
  • Neuroprotective Agents
  • naringin
  • 1-Methyl-4-phenylpyridinium
  • Dopamine